Capital Fund Management (CFM)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-12,767
Closed -$3.02M 1275
2020
Q3
$3.02M Sell
12,767
-172
-1% -$39.1K 0.04% 510
2020
Q2
$2.57M Sell
12,939
-22,432
-63% -$4.18M 0.04% 431
2020
Q1
$6.49M Sell
35,371
-17,915
-34% -$3.19M 0.1% 263
2019
Q4
$8.89M Sell
53,286
-13,616
-20% -$2.03M 0.07% 380
2019
Q3
$8.77M Buy
66,902
+504
+0.8% +$65.6K 0.08% 321
2019
Q2
$8.06M Buy
66,398
+5,261
+9% +$624K 0.07% 364
2019
Q1
$7.54M Buy
61,137
+50,999
+503% +$6.4M 0.07% 374
2018
Q4
$1.19M Buy
10,138
+4,738
+88% +$558K 0.01% 1048
2018
Q3
$675K Buy
+5,400
New +$596K ﹤0.01% 1498
2018
Q1
Sell
-8,000
Closed -$422K 1807
2017
Q4
$422K Buy
+8,000
New +$422K ﹤0.01% 1514
2014
Q3
Sell
-36,143
Closed -$605K 1501
2014
Q2
$605K Buy
+36,143
New +$512K 0.01% 1144
2014
Q1
Sell
-22,467
Closed -$329K 1674
2013
Q4
$329K Sell
22,467
-7,390
-25% -$119K ﹤0.01% 1418
2013
Q3
$514K Buy
+29,857
New +$443K 0.01% 1141

Other funds holding AMED

Capital Fund Management (CFM)'s AMED Position: Q4 2020 in Review

Capital Fund Management (CFM) sold out of Amedisys (AMED) in Q4 2020, closing a stake of 12,767 shares — an estimated $3.02M sold.

Capital Fund Management (CFM) first reported a position in AMED in Q3 2013 and held it in 13 quarters. The position peaked at $8.89M in Q4 2019. 396 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Capital Fund Management (CFM) reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 12,767 Amedisys shares in Q4 2020, an estimated $3.02M.
  • Capital Fund Management (CFM) first reported a position in Amedisys in Q3 2013 and held it in 13 quarters.
  • Capital Fund Management (CFM)'s Amedisys position peaked at $8.89M in Q4 2019.
  • 396 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2020, filed 12 Feb 2021.